A US judge ruled that blockchain-based publishing company LBRY Inc offered its digital assets as securities without registering them.
The US Securities and Exchange Commission (SEC) sued LBRY last year for violating a US law by selling its LBRY Credits without registering them as securities.
According to US District Judge Paul Barbadoro, no reasonable jury could reject the SEC's claim that LBRY offered the credits as an investment in its content distribution network.
Barbadoro added that "nothing in the case law suggests that a token with both consumptive and speculative uses cannot be sold as an investment contract."
The judge also rejected LBRY's defense that it lacked notice that the law applied to it.
LBRY CEO Jeremy Kauffman said the decision sets a standard that would deem "almost every cryptocurrency" a security, threatening the US cryptocurrency industry.
LBRY argued that, unlike in other cases where certain digital tokens were deemed securities, its credits were functional as currency on its platform, allowing content creators to earn cash and accept tips.
The judge also rejected LBRY's defense that it lacked notice that the law applied to it. The company had said its case was the first where the SEC alleged registration violations against an issuer of digital tokens that did not conduct an initial coin offering.


Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns




